series-a
Stage
2018
Founded
1
Investors
About
DIANA Biotechnologies develops innovative solutions for diagnostic and academic labs, including PCR products, custom oligonucleotide synthesis, monoclonal antibody development, and drug discovery services. Founded in 2018, the company became the largest producer of COVID-19 tests in Czechia and focuses on molecular diagnostics and drug discovery.
Explore DIANA Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.